Top compounds associated with response to TM4SF19-TCTEX1D2


Feature Type Standardized
Nominal ANOVA
mRNA MI-2 CTRPv2 pan-cancer AAC -0.13 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC -0.085 0.02
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC -0.081 0.02
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.02
mRNA BYL-719 CTRPv2 pan-cancer AAC -0.099 0.02
mRNA ML210 CTRPv2 pan-cancer AAC -0.075 0.02
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.083 0.02
mRNA cediranib CTRPv2 pan-cancer AAC -0.12 0.02
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.097 0.02
Download CSV